Phase2Phase Biopharma
Overview
Phase2Phase Biopharma is a Swedish life science firm founded in 2017 that provides consulting services and invests its profits in early-stage life science ventures.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Akiram Therapeutics | Jan 2023 | VC Round | Co-investor |
| AAX Biotech AB | Oct 2024 | VC Round | Co-investor |
| Key2Brain | Oct 2024 | VC Round | Co-investor |
| Vakona | Apr 2025 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Phase2Phase Biopharma based?
Phase2Phase Biopharma is headquartered in Stockholm, Sweden.
When was Phase2Phase Biopharma founded?
Phase2Phase Biopharma was founded in 2017.
How many portfolio companies does Phase2Phase Biopharma have?
Phase2Phase Biopharma has 4 portfolio companies in Caplight's dataset.
What are some companies in Phase2Phase Biopharma's portfolio?
Portfolio companies visible on Caplight include Akiram Therapeutics, AAX Biotech AB, Key2Brain, Vakona.
What was Phase2Phase Biopharma's most recent investment shown here?
Phase2Phase Biopharma's most recent investment in this portfolio sample was in Vakona in 2025.
What sectors does Phase2Phase Biopharma focus on?
Phase2Phase Biopharma focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Phase2Phase Biopharma focus on?
Stage focus information for Phase2Phase Biopharma is not publicly available.